Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (8)

2017

  1. Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson's Disease

    ACS Omega, Vol. 2, Núm. 8, pp. 5215-5220

  2. Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease

    Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 731-748

  3. Phosphodiesterase7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo

    Stem Cells, Vol. 35, Núm. 2, pp. 458-472

  4. Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases

    Journal of Medicinal Chemistry, Vol. 60, Núm. 12, pp. 4983-5001

2015

  1. PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

    British Journal of Pharmacology, Vol. 172, Núm. 17, pp. 4277-4290

  2. Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats

    Stem Cells Translational Medicine, Vol. 4, Núm. 6, pp. 564-575

  3. Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1160-1173

2014

  1. Modulation of cAMP-specific PDE without emetogenic activity: New sulfide-like PDE7 inhibitors

    Journal of Medicinal Chemistry, Vol. 57, Núm. 20, pp. 8590-8607